News Category
Quantum BioPharma received FDA clearance to begin Phase 2 trials for its novel MS candidate Lucid-MS, which targets myelin repair rather than immune m...
PX1 Research's new domestic manufacturing protocol applies cGMP quality control and seven-stage HPLC purity verification, ensuring 99%+ purity with ba...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola, potentially offering a more accessibl...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Quantum BioPharma's FDA approval to begin Phase 2 trials for its novel MS drug Lucid-MS could herald a shift from immune-modulating therapies to neuro...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, driven by TONMYA's strong sales, while the company progresses its clinical pipeline an...
Tonix Pharmaceuticals announced Q2 2026 revenue of $13.5 million, up from $2 million a year ago, fueled by TONMYA sales, and provided updates on its p...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through key clinical and regulatory milestones, potentially offerin...
Quantum BioPharma is progressing its two-pronged approach to neurological health, targeting multiple sclerosis with Lucid-MS and alcohol-related effec...
Quantum BioPharma is progressing two distinct approaches—an investigational MS therapy and a dietary supplement—to address neurological and alcohol-re...
VERAXA Biotech's advanced antibody engineering platform positions it to capitalize on significant pharmaceutical investment in ADCs and T-cell engager...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer highlights the dangers of undercooked pork and the urgent need for imp...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its IP portfolio, strengthenin...
A novel liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatme...
GeoVax announced completion of manufacturing, regulatory, clinical, and preclinical milestones for its mpox/smallpox vaccine GEO-MVA, supporting initi...
Onco-Innovations is combining PNKP-targeted therapy, nanoparticle delivery, and AI to develop ONC010, aiming to improve cancer treatment efficacy and ...
Nagoya University researchers discovered that the ancient protein C3, when produced by tumor cells, may boost the effectiveness of immunotherapy by ac...
VolitionRx's new Capture-Seq technology, detailed in a peer-reviewed paper, achieves over 99% pure ctDNA isolation, potentially transforming cancer de...
Tonix Pharmaceuticals announced its participation in two key investor conferences, providing a platform to discuss its commercial-stage CNS and immuno...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate program into the next development stage and expanded its intellectual property...
NeuroThera Labs has initiated a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a novel cannabinoid-based treatment for Tourette Synd...
SRX Global's investment in Vistagen Therapeutics signals a strategic move to unlock shareholder value in a neuroscience biopharmaceutical company.
SRX Global's investment in Vistagen Therapeutics signals a strategic move to unlock shareholder value in a late-stage biopharmaceutical company.
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached halfway enrollment, with preliminary PET imaging showing en...
Biotech Labz Supply Inc. has broadened its online catalog of high-purity research peptides, now offering 11 compounds with batch-specific certificate ...
Oncotelic Therapeutics will showcase its latest clinical progress, including Phase 1b trial advancement and AI-driven platforms, at the OTCQB Virtual ...
Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 study of TNX-4800, a long-acting antibody for Lyme disease prevention, po...
Recent independent findings suggest that licensed Ebola vaccines may induce cross-reactive immune responses, supporting broader filovirus vaccine deve...
Regentis Biomaterials is progressing its GelrinC platform, a cell-free, off-the-shelf hydrogel, targeting a major unmet need in cartilage repair with ...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached halfway enrollment, with early PET imaging signals potentia...
NeuroThera Labs announced that its quantum platform successfully processed real-world clinical data through a complete hybrid quantum-classical workfl...
NeuroOne Medical Technologies released a white paper detailing its StereoCED™ platform designed to streamline and scale CNS drug delivery via robotic-...
VERAXA Biotech has promoted antibody therapeutics specialist Dr. Christoph Erkel to Chief Scientific Officer as the company prepares its proprietary B...
Onco-Innovations Limited announced the closing of a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP to fund its ONC...
Lexaria Bioscience Corp. announced a 1-for-15 reverse stock split effective August 3, 2026, aiming to boost its share price above $1.00 to meet Nasdaq...
VolitionRx announced increasing clinical support for its Nu.Q NETs assay as a biomarker for sepsis, with studies showing its ability to distinguish se...
Instinct Bio announced a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetic products in the U.S. and supply exosomes for r...
Renaissance BioScience Corp. has appointed Dr. James Tansey, a seasoned entrepreneur and academic, to its board, bringing expertise in life sciences c...
BRAIN Biotech AG announces Dr. Sven K. Weber as CEO effective October 1, 2026, succeeding Adriaan Moelker who retires after six years, marking a leade...
VERAXA Biotech announced it has filed new patent applications in the first half of 2026, expanding its intellectual property portfolio to over 50 gran...
MindBio Therapeutics has completed and delivered its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, using voice analysis to screen...
VERAXA Biotech strengthens its scientific leadership by appointing Dr. Christoph Erkel as Chief Scientific Officer to advance its proprietary BiTAC(R)...
VERAXA Biotech AG has expanded its intellectual property portfolio with new patent filings for its BiTAC-TCE and BiTAC-ADC platforms, strengthening pr...
Greenland Mines has obtained a Canadian patent for Klotho-based gene therapies, expanding its IP portfolio and advancing candidates for Alzheimer's, P...
Quantum BioPharma's executive discussed the company's strategy for advancing Lucid-MS for multiple sclerosis and the commercial opportunity for unbuzz...
VERAXA Biotech shareholders approved key governance and financing proposals with over 99.94% support, aiming to bolster the company's long-term growth...
Greenland Mines Ltd. announced a Canadian patent for Klotho-based gene therapies targeting cognition, memory, and neurodegenerative diseases, expandin...
NanoViricides has submitted an application to begin a Phase II trial of its NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approve...
